Theodora Kanni, Maria Argyropoulou, Themistoklis Spyridopoulos, Aikaterini Pistiki, Michael Stecher, Charles A Dinarello, John Simard, Evangelos J. Giamarellos-Bourboulis

MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study

Journal of Investigative Dermatology 2018 Apr;138(4):795-801
DOI: 10.1016/j.jid.2017.10.030View article 🡇

Funding

This study was supported in part by XBiotech (Austin, TX) and the Hellenic Institute for the Study of Sepsis.

Keywords: Hidradenitis Suppurativa
Related Study: HIDRA04